What are the effects, risks, and recommended use of anticholinergic medications, particularly in older adults or patients with cognitive impairment?

Anticholinergic Medications: Avoid in Older Adults Due to Serious Cognitive and Safety Risks

Anticholinergic medications should be minimized or avoided entirely in older adults, particularly those with cognitive impairment, due to their strong association with delirium, cognitive decline, dementia risk, falls, and mortality. 1, 2

Key Adverse Effects in Older Adults

Anticholinergic medications cause broad muscarinic receptor blockade leading to multiple serious complications 1:

Central Nervous System Effects

• Delirium and acute confusion
• Slowed comprehension and cognitive impairment
• Increased dementia risk with long-term use (OR 1.50 for long-term use ≥365 days) 3
• Dose-response relationship: cumulative burden increases dementia risk 4

Peripheral Anticholinergic Effects

• Vision impairment and blurred vision
• Urinary retention
• Constipation
• Sedation
• Increased fall risk with resulting injuries 1

Mortality Risk

Long-term anticholinergic use is associated with increased mortality in older adults 5

High-Risk Medications to Avoid

The following medication classes have particularly problematic anticholinergic effects in older adults 1:

Old Antihistamines

• Diphenhydramine (Benadryl)
• Hydroxyzine

Muscle Relaxants

• Cyclobenzaprine
• Metaxalone
• Carisoprodol
• Orphenadrine
• Methocarbamol
• Chlorzoxazone

Overactive Bladder Medications

• Oxybutynin (particularly problematic)

First-Generation Antipsychotics with Anticholinergic Properties

• Chlorpromazine - sedating with significant anticholinergic effects 6
• Methotrimeprazine (Levomepromazine) - sedating with anticholinergic effects, may cause orthostatic hypotension 6

Clinical Decision Algorithm

Step 1: Identify Current Anticholinergic Burden

• Review all medications including over-the-counter drugs 1
• Use the Anticholinergic Cognitive Burden (ACB) Scale to quantify exposure 3, 7
• Medications with ACB score ≥3 are highest risk 7

Step 2: Assess Patient Risk Factors

Highest risk patients requiring immediate intervention:

• Age ≥65 years
• Existing cognitive impairment or dementia 2, 8
• Multiple anticholinergic medications (polypharmacy)
• Cumulative anticholinergic burden
• History of falls or delirium

Step 3: Implement Safer Alternatives

For Depression/Neuropathic Pain:

• Avoid tricyclic antidepressants (TCAs) with high anticholinergic properties 2
• Consider SSRIs, SNRIs, or gabapentinoids instead

For Urge Urinary Incontinence:

• Avoid oxybutynin 1
• Consider behavioral interventions first
• If medication needed, use agents with lower anticholinergic burden

For Insomnia/Anxiety:

• Avoid diphenhydramine and hydroxyzine 1
• Consider cognitive behavioral therapy 1
• If medication necessary, use non-anticholinergic alternatives with caution

For Muscle Spasm:

• Avoid all anticholinergic muscle relaxants 1
• Use physical therapy, heat/cold therapy
• Consider acetaminophen on scheduled basis for musculoskeletal pain 1

Step 4: Deprescribing Strategy

Safe tapering approach 1:

• Taper gradually rather than abrupt discontinuation
• Monitor for withdrawal symptoms
• Especially important for benzodiazepines and long-term medications
• Consider safer non-pharmacological alternatives during taper

Critical Warnings for Specific Populations

Patients with Dementia

• Anticholinergic exposure predicts worse cognitive and functional outcomes even after discontinuation 8
• Patients with Alzheimer's disease on anticholinergics at baseline showed worse functional scores at 1-year follow-up despite medication cessation 8
• Anticholinergic use remained stable in dementia patients (unlike general older population where it declined), indicating ongoing inappropriate prescribing 9

Patients with Parkinson's Disease or Lewy Body Dementia

• Absolutely avoid first-generation antipsychotics like haloperidol due to extrapyramidal side effect risk 6
• Do not use benztropine or trihexyphenidyl to counteract antipsychotic side effects 10

Older Adults with Multiple Comorbidities

• Increased sensitivity to psychomotor impairment 11
• Higher risk of falls, fractures, and subdural hematomas 11
• More susceptible to complications from increased intraocular pressure, benign prostatic hypertrophy, and pre-existing cognitive impairment 11

Evidence Strength and Nuances

The evidence linking anticholinergic medications to cognitive decline and dementia is moderate to strong across multiple observational studies 3, 4. However, a definitive causal relationship cannot yet be established because studies are observational with considerable risk of bias 3. Despite this limitation, the consistency of findings across studies, the dose-response relationship, and the severity of potential harms justify aggressive avoidance strategies in clinical practice.

Important caveat: Some studies show that prior anticholinergic use may have lasting effects on cognitive trajectory even after discontinuation 8, suggesting that prevention of exposure is more effective than later cessation.

Common Pitfalls to Avoid

1. Missing over-the-counter medications: Patients often don't report diphenhydramine use for sleep or allergies
2. Assuming bedtime-only dosing is safe: First-generation antihistamines cause next-day impairment without subjective drowsiness awareness 11
3. Using anticholinergics to treat antipsychotic side effects: This compounds the problem rather than solving it 10
4. Failing to recognize cumulative burden: Multiple medications with mild anticholinergic effects add up 4
5. Not considering anticholinergics when evaluating new cognitive symptoms: Review medication list if cognitive impairment develops 12

Monitoring Requirements

• Regular medication list review in all older adults 1, 12
• Immediate review if cognitive impairment develops or worsens 12
• Document cognitive function (e.g., MMSE) at baseline and follow-up when anticholinergics cannot be avoided 8
• Assess for falls, urinary retention, constipation, and vision changes